Raltitrexed(112887-68-0)
- Name: Raltitrexed
- Synonyms:D1694;Tomudex (TN);L-Glutamic acid,N-[[5-[[(1,4-dihydro-2- methyl-4-oxo-6-quinazolinyl)methyl]methylamino]- 2-thienyl]carbonyl]-;ZD1694;Raltitrexed (JAN/USAN);D 1694;(2S)-2-[[5-[methyl-[(2-methyl-4-oxo-1H-quinazolin-6-yl)methyl]amino]thiophene-2-carbonyl]amino]pentanedioic acid;L-Glutamic acid, N-((5-(((1,4-dihydro-2-methyl-4-oxo-6-quinazolinyl)methyl)methylamino)-2-thienyl)carbonyl)-;Tomudex;ICI-D1694;ICI D1694;N-(5-(N-(3,4-Dihydro-2-methyl-4-oxoquinazolin-6-ylmethyl)-N-methylamino)-2-thenoyl)-L-glutamic acid;(S)-2-[(1-{5-[Methyl-(2-methyl-4-oxo-3,4-dihydro-quinazolin-6-ylmethyl)-amino]-thiophen-2-yl}-methanoyl)-amino]-pentanedioic acid;ZD 1694;D-1694;
- Molecular Formula:C21H22N4O6S
- Molecular Weight:458.495
- CAS Registry Number:112887-68-0
- EINECS:652-997-2
- Melting Point:176-180 °C
- Water Solubility:
Other Product
- 72930-66-6/1-({(4R,7S,13S,16S)-7-(2-amino-2-oxoethyl)-16-benzyl-13-[(2S)-butan-2-yl]-10-[(1R)-1-hydroxyethyl]-20,20-dimethyl-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl}carbonyl)-L-prolyl-L-leucylglycinamide
- 26569-08-4/bis(nonylphenyl) phosphonate
- 168433-95-2/Lanost-7-en-18-oicacid, 16-(acetyloxy)-20-hydroxy-3-[(O-3-O-methyl-b-D-glucopyranosyl-(1®3)-O-b-D-xylopyranosyl-(1®4)-O-[b-D-xylopyranosyl-(1®2)]-O-6-deoxy-b-D-glucopyranosyl-(1®2)-4-O-sulfo-b-D-xylopyranosyl)oxy]-23-oxo-, g-lactone, sodium salt (1:1), (3b,16b)-
- 68783-79-9/Quaternary ammonium compounds, N-(2-hydroxypropyl)-N,N,N,N-tetramethyl-N-tallow alkyltrimethylenedi-, dichlorides
- 131984-83-3/9H-2,26:18,21-Dietheno-4,8-metheno-22H-[1,- 3]dioxolo[4,5-g]pyrido[3',2':14,15][1,11]dioxacycloeicosino[ 2,3,4-ij]isoquinoline,23-acetyl- 9a,10,11,12,22a,23,24,25-octahydro-5,28- dimethoxy-10-methyl-,(9aS,22aR)-
- 7596-47-6/(2Z)-5-bromo-4-hydroxyhex-2-enoic acid
- 146269-94-5/AF2 Neuropeptide
- 68440-17-5/Fatty acids, rape-oil, sodium salts
- 85506-34-9/Bis(isodecanoato-O)(isooctanoato-O)cerium
- 68444-07-5/potassium 4-benzamido-2-[[1-(2-chlorophenyl)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-4-yl]azo]benzenesulphonate
- 20932-80-3/trimethyl-[1,1,4,4,4-pentakis(trimethylsilyl)but-2-ynyl]silane
- 62893-19-0/Cefoperazone
- 56453-08-8/disodium 5(or 6)-carboxylato-4-hexylcyclohex-2-ene-1-octanoate
- 68154-65-4/Fatty acids, fish-oil, compds. with triethanolamine
- 195987-41-8/(4R)-4-benzyl-2-(3H-imidazol-4-ylmethyl)-5-thiophen-2-ylsulfonyl-2,5-diazabicyclo[5.4.0]undeca-8,10,12-triene-9-carbonitrile
- 1250-96-0/(3beta,5beta,8xi,9xi)-3-(formyloxy)-14-hydroxycard-20(22)-enolide
- 51541-77-6/3,3-Diselenobis-1-propanamine
- 169168-53-0/(2R,3R)-2-methyl-1,1-dioxidotetrahydrothiophen-3-yl [(2R,3R)-4-[(3aR,6S,7aS)-6-(tert-butylcarbamoyl)hexahydrothieno[3,2-c]pyridin-5(4H)-yl]-3-hydroxy-1-(phenylsulfanyl)butan-2-yl]carbamate
- 15604-81-6/N-[bis(dimethylamino)phosphoryloxy-dimethylamino-phosphoryl]-N-methyl-methanamine; lead(+2) cation; diperchlorate
- 112887-68-0/Raltitrexed
- 101564-14-1/(1-Methyl-3-piperidyl)methyl-(1-hydroxycyclohexyl)phenylacetate hydroc hloride
- 69242-95-1/9-({4-[(ethylsulfonyl)amino]-2-methoxyphenyl}amino)acridine-4-carboxamide hydrochloride (1:1)
- 37081-76-8/7-hydroxyamoxapine
- 101931-19-5/N-[1-(naphthalen-1-yl)ethyl]-4,5-dihydro-1,3-oxazol-2-amine
- 82556-10-3/3,4-pyruvylated galactose
- 6709-22-4/2,2,3-trimethylcyclopent-3-enecarboxylic acid
- 5336-62-9/1-(5-methoxy-2-methylphenyl)-N,N-dimethylmethanamine
- 58324-14-4/3-methoxy-4-(pyrrolidin-1-ylmethyl)acridin-9(10H)-one
- 75686-51-0/10-pentylsparteine 2,3-dihydroxybutanedioate (1:1)
- 93803-76-0/5-oxo-L-proline, compound with 8-benzyl-7-[2-[ethyl(2-hydroxyethyl)amino]ethyl]-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione (1:1)